The starting material 5-fluoro-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-acetic acid was prepared from 5-fluorouracil and bromoacetic acid following the method of the literature [1] . The key intermediate methyl 2(R)-(5-fluorouracil-1-aceto)amino-2-phenyl acetate was synthesized from 5-fluorouracil-1-acetic acid, dicyclohexyl carbodiimide (dcc), and 1-hydroxybenzotriazole (btOH). A solution (25 ml) of dcc (0.024 mol) in dimethylformamide (dmf) was dropped in a dmf solution (75 ml) of 5-fluorouracil-1-acetic acid (0.02 mol) and btOH (0.02 mol) at 273 K.
Source of material
The starting material 5-fluoro-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-acetic acid was prepared from 5-fluorouracil and bromoacetic acid following the method of the literature [1] . The key intermediate methyl 2(R)-(5-fluorouracil-1-aceto)amino-2-phenyl acetate was synthesized from 5-fluorouracil-1-acetic acid, dicyclohexyl carbodiimide (dcc), and 1-hydroxybenzotriazole (btOH). A solution (25 ml) of dcc (0.024 mol) in dimethylformamide (dmf) was dropped in a dmf solution (75 ml) of 5-fluorouracil-1-acetic acid (0.02 mol) and btOH (0.02 mol) at 273 K. After 5 h reaction at room temperature, methyl 2(R)-amino-2-phenyl acetate (0.02 mol) and triethylamine (0.02 mol) were added to the above mixture. After 4 h stirring, a white solid methyl 2(R)-(5-fluorouracil-1-aceto)amino-2-phenyl acetate was obtained after filtration, reduced pressure distillation of dmf, and column chromatography separation. The title compound was obtained by hydrolysis with 1 M sodium hydroxide solution. The purified product was dissolved in 95 % ethanol and single crystals were separated after 10 d. Mass, IR, 1 H NMR and 13 C NMR are available in the CIF.
Discussion

5-Fluorouracil (5FU)
is an antimetabolite with good antitumor activity but has side effects [1] [2] [3] . Much attention has been paid to the derivatives of 5FU and their anticancer activities [4] [5] [6] . In an extension of this research, we report the crystal structure of a peptide derivative of 5FU, 2(R)-(5-fluorouracil-1-yl)acetyl-2-phenylglycin.
The atoms (C1, C2, C3, C4, N1 and N2) in the heterocyclic ring and the atoms (C9 C14) of the benzene ring are essentially planar with r.m.s. deviations of 0.0104 Å and 0.0100 Å, respectively. The dihedral angle between the two rings is 53.8(2) Å. Moreover, the N3C6 bond distance (1.327 ( 
